Login     Register  
    Home  |   Privacy & Security  |   Search  |   About Us  |   Contact Us  |   Disclaimer
BioOntario - Ag Biotech,  Biotechnology and Pharmaceutical Portal for Ontario Canada SMi’s 3rd Annual Drug Discovery Chemistry
Site Search:
    Home Innovation Community Patient Engagement News Events
 Patient Engagement   Show all: Patient Engagement

 

Co-Creation vs Open Innovation: Benefits, Risks and Examples
The focus of this article is on co-creation vs open innovation and highlight some benefits, risks and examples of each methodology.
Read More...

What is Design Thinking?
Some of the world’s leading brands, such as Apple, Google, Samsung and GE, have rapidly adopted the Design Thinking approach, and Design Thinking is being taught at leading universities around the world, including d.school, Stanford, Harvard and MIT. But do you know what Design Thinking is?
Read More...

Connecting the Key Stakeholders in Innovation in the Cardiovascular Community
PCR Innovators Day Paris is a one-day event connecting the Key Stakeholders in Innovation in the Cardiovascular Community.
Read More...

The Patient Innovation European Tour
The exhibition features projects related to citizens who took action and became scientists, and shows that you don’t have to be in a lab and wearing a white coat to make a difference.
Read More...

Patient Centered Apps
Pharma companies have been pushing the envelope when to comes to patient centered apps.
Read More...

Putting Humans at the Center of Health Care Innovation
An alternative model of healthcare is emerging-one that is human-centered design and co-creation, a set of approaches that can accelerate and humanize healthcare innovation.
Read More...

Patient Advocacy Group Creates Patient Education Tools for MS
The education tool will support shared decision-making for patients with multiple sclerosis.
Read More...

Drug delivery trends from Paris: Bluetooth, patient centricity and disposable tech
A patient-controlled injector and a prefilled pen for patients with hand dexterity issues were among the drug delivery technologies celebrated at PharmaPack Europe’s awards this year.
Read More...

Why Pharma Needs A New Approach To Patient Engagement In Drug Development
Pharmaceutical companies have yet to maximally engage with patients to learn what they value before developing a product.
Read More...

Available on demand: Improving patient adherence, engagement and outcomes through innovations in drug delivery
Read More...

Solving Big Problems to Disrupt Patient Outcomes
By Mir Imran, Chairman and Chief Executive Officer, Rani Therapeutics
Over the years, I have spent considerable time thinking about the process of innovation and evaluating what has led me to be successful in creating products and companies.
Read More...

Rebalancing the patient experience: 20 years of a pendulum swing
This article considers the evolution of the patient experience movement including moving from a belief system in which patients and families are solely the recipients of care to a model in which patients and families are co-designing treatment plans, systems and policies.
Read More...

The Difference Between Patient Education and Health Literacy
Understanding the difference between patient education and health literacy can assist HCPs with targeted patient engagement programs.
Read More...

Opinion: How an open approach to patents could help build a sustainable future
A protectionist approach to intellectual property is designed to protect and prolong the lifecycle of existing technologies, and allow innovators to capture the profits from their creations. In a paper published with colleagues from universities in Germany and India, we examined how this also makes it harder for new and more sustainable technologies to be developed and adopted.
Read More...

Patient engagement a new frontier for drug makers
Right now, any interaction between drug companies and patients typically comes after a drug has been developed and released, when drug makers look to patients to provide “patient reported outcomes” to determine whether a drug is having its intended effects and meeting patients’ expectations.
However, the push is to engage patients earlier in the process...
Read More...

Converging Markets, Technologies, and Medical Advancements Drive New Opportunities and Innovations in Digital Healthcare
New opportunities and challenges are being created as healthcare delivery evolves through the continuum of care
Read More...

Seniors for Seniors: A Mentorship Program to Prevent Social Isolation and Enable Healthy Living
Toolkit
A 5 seminar series to engage seniors on the topic of social isolation and enable participants to design a healthy living social network. The mentorship programs seeks seniors to empower other fellow seniors through discussion, analysis and social innovation.
Read More...

Capturing the Value of Patient Engagement: Summary of Results of the Study of Patient-Centric Initiatives in Drug Development
Read this executive summary and detailed study results that include key insights in the following areas: adoption of patient-centric initiatives by pharmaceutical and biotech companies, barriers to adoption of patient-centric initiatives, comparative analytics and results of patient-centric initiatives.
Read More...

The Evolution of Patient Engagement at FDA
Although advancements in incorporating the patient voice have been made over the past few decades, there are still patients who feel frustrated with the rate of progress.
Read More...

Will GSK’s new ‘ethical’ approach to its customers deliver commercial success?
This is the question eyeforpharma answers in its latest whitepaper on GSK's radical new customer engagement model. Read the full paper here
https://goo.gl/w0H9k7

Lessons for Patient Driven Innovation: Rebuild Personas According to Your Next Product Innovation
By exclusively focusing on your persona’s one main need and trying hard to fulfill that need with your product, you can build the next feature with a more focused vision.
Read More...

Culture and Process Change for Patient Engagement
Patient Focused Medicines Development (PFMD) is a not-for-profit independent multinational coalition of patients, patient stakeholders, and the pharmaceutical industry with interests across diverse disease areas and conditions.
Read More...

Lessons on Design Thinking from P&G and Pfizer
Learn more on the how, and why, both P&G and Pfizer view design thinking as a tool set that helps individuals and companies problem-solve.
Read More...

Opening the Door to Patients
The Open House concept was born towards the end of 2014 when Janssen was approached by a large patient group in the oncology space. The group asked if the company would be interested in supporting them in work that they felt would contribute towards improving patient outcomes. As discussions progressed, it became clear that a new model of interaction might be appropriate.
Read More...

It takes two to tango: how shared decision making can help patients and providers make better decisions together
Shared Decision Making
Thursday, September 15, 2016 at 1 PM in Paul Brest Hall, Stanford University.
You make decisions every day. Some are good; some are not as good. Did you know there is a science to decision making that can help people make better decisions more often? In collaboration with Eli Lilly, Medicine X will facilitate a half-day design workshop about improving decision making for patients and providers.
Read More...

Do Patents Promote or Hinder Innovation
A petition recently filed with the Supreme Court triggers renewed debate about the role of patents in the diagnostics sector.
Read More...

Innovation Communities
The Communities of Practice concept is a key lever for innovation, but often overlooked. The best innovation programs leverage CoPs to support continuous innovation across an organization.
Read More...

WEBINAR: How Pfizer Built a Global Innovator Network
Pfizer's Daniel Seewald explores the keys to success in creating a global network of innovation “champions” over scarcely more than two years.
Read More...

Using the Internet to Raise Disease Awareness
The continued rise of social media and the various fundraiser pages can be great for any disease awareness campaign. Patients who have the diseases that are being campaigned for are more likely to engage via social media than the other campaign methods.
Read More...

Strategies for Patient Engagement
Positive and credible engagement of patients is critical for completion of clinical trials and to achieve business results. The CLEAR method leverages: credibility, literacy, expectation management, accessibility and that relates to patients.
Read More...
Precision Medicine Intiative
Precision Medicine is an innovative approach that takes into account individual differences in people’s genes, environments, and lifestyles.
Read More...

Patient Engagement Practices in Clinical Research among Patient Groups, Industry, and Academia in the United States: A Survey
This study aims to gain a better understanding of attitudes and practices for engaging patient groups.

Partnership between Pharma and Patients

Jane Griffiths, Company Group Chairman, Janssen EMEA discusses the relationship between industry and patients.
Read More...

Learning more from Patients Regarding Engagement
What can learn pharma from patients regarding engagement expectations including data collection, communication and the usage of technology.
Read More...

A Focus on People, Ideas and Culture: Bayers Model of Innovation
Bayer's model of innovation is a holistic model for people and their ideas. The model assists with the creation, nurturing, and enhancing of people and ideas.

Engaging patients for drug repurposing: Mapping the patient engagement continuum
The chance exists to engage patients directly through crowd research and patient journey mapping as well as indirectly through patient health information to seek new opportunities for drug repurposing. Case examples are used in this article to shed light on programs that have been initiated by a variety of stakeholders including patients themselves to elucidate drugs that potentially are candidates for drug repurposing.

Patient Research Priorities
Is there a disparity between what patients think are research priorities and the focus of academic/industry studies? Patients become experts in regard to disease and health management; their research priorities can often differ from those of academic/industry based researchers.
Read More...

Patient Engagement/Engaged Thinking Social Community Launched
Visit CanBiotech's new patient engagement and engaged thinking community. Participate in the development of the concept of engaged thinking in health innovation and the identification of "lead patients".
Read More...

Listening to Patients
In its own move to patient centricity, Sanofi seeks to use practical cases internally to illustrate to staff how things can change toward patient centricity.
Read More...

Using the Site Privacy & Security Statement Advertise with us Event Postings CanBiotech Newsletters

© 2000-2018 CanBiotech™ Inc.